Johnson & Johnson’s Q2 Profit Matches View, but Forecast Cut on Recalls (JNJ)

By Dividend.com,  July 20, 2010, 09:00:22 AM EDT

Health products maker Johnson & Johnson ( JNJ ) on Tuesday posted a second quarter profit that met analyst expectations, but lowered its full-year outlook for the second time, citing recent product recalls.

The New Brunswick, NJ-based company reported second quarter net income of $3.45 billion, or $1.23 per share, compared with $3.21 billion, or $1.15 per share, in the year-ago period. Excluding one-time items, adjusted profit was $1.21 per share.

Revenue edged less than 1% higher from last year, to $15.33 billion.

On average, Wall Street analysts expected a matching adjusted profit of $1.21 per share, albeit on higher revenue of $15.69 billion.

Looking ahead, the company cut its full-year forecast for the second time, citing recent recalls of certain over-the-counter medicines, as well as a plant suspension and currency effects. It now expects earnings of $4.65 to $4.75 per share for the year, while analysts are looking for $4.81.

Johnson & Johnson shares fell 97 cents, or -1.6%, in premarket trading Tuesday.

The Bottom Line
We have been recommending shares of JNJ since Oct.8, 2009, when the stock was trading at $60.71. The company has a 3.63% dividend yield, based on last night's closing stock price of $59.57.

Johnson & Johnson ( JNJ ) is a "recommended" dividend stock, holding a Dividend.com DARS™ Rating of 3.5 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks , as well as a detailed explanation of our ratings system here .




The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.


This article appears in: Investing, Stocks

Referenced Stocks: JNJ



Latest News Video

Ireland Rejects Blame in Apple Tax Row
Ireland Rejects Blame in Apple Tax ...
"Our Prayers Are With the People of Oklahoma" -Obama
"Our Prayers Are With the People of...


Sign-in
Existing NASDAQ.com member? Log in here.

By signing into to the site using any of the third-party services above, you agree to NASDAQ.com's Terms of Use.

From Our Trusted News Source





Most Active by Volume:

Company Last Sale Change Net / %
BAC $ 13.48 0.03  0.22%
F $ 14.837 0.21  1.42%
CLWR $ 3.41 0.15  4.60%
YGE $ 3.785 0.69  22.10%
MSFT $ 34.91 0.17  0.48%
INTC $ 24.225 0.15  0.60%
CSCO $ 23.7409 0.20  0.85%
PFE $ 28.47 0.23  0.80%